These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 2934863)
1. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863 [TBL] [Abstract][Full Text] [Related]
2. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
3. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. Ostermann G; Till U; Thielmann K Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754 [TBL] [Abstract][Full Text] [Related]
4. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation. Zatta A; Zanetti A; Dejana E; Prosdocimi M Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218 [TBL] [Abstract][Full Text] [Related]
5. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. May JA; Heptinstall S; Cole AT; Hawkey CJ Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371 [TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S; Joseph S; Kakkar VV Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746 [TBL] [Abstract][Full Text] [Related]
7. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. Fouque F; Vargaftig BB Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269 [TBL] [Abstract][Full Text] [Related]
8. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin. Tandon NN; Ordinas A; Jamieson GA Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815 [TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin on platelet aggregation in vitro]. RĂ³ka L; Isert D Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949 [TBL] [Abstract][Full Text] [Related]
10. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. Vargaftig BB; Fouque F; Benveniste J; Odiot J Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036 [TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Kornecki E; Ehrlich YH; Lenox RH Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550 [TBL] [Abstract][Full Text] [Related]
12. Unexpected effects of aurin tricarboxylic acid on human platelets. Kinlough-Rathbone RL; Packham MA Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166 [TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents. Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498 [TBL] [Abstract][Full Text] [Related]
14. Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin. Takahashi O Food Chem Toxicol; 1991 Mar; 29(3):173-83. PubMed ID: 1903353 [TBL] [Abstract][Full Text] [Related]
15. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Steen VM; Holmsen H; Aarbakke G Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557 [TBL] [Abstract][Full Text] [Related]
16. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. Altman R; Scazziota A Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757 [TBL] [Abstract][Full Text] [Related]
17. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). Steiner M; Landolfi R; Motola NC; Turcotte JG Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503 [TBL] [Abstract][Full Text] [Related]
18. Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro. Marcus AJ; Safier LB; Ullman HL; Wong KT; Broekman MJ; Weksler BB; Kaplan KL Blood; 1981 Nov; 58(5):1027-31. PubMed ID: 6457658 [TBL] [Abstract][Full Text] [Related]
19. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
20. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]